Golden Cross Stocks · Biological Products, (No Diagnostic Substances)
5 stocks match the Golden Cross Stocks screen. Stocks whose 50-day moving average has just crossed above their 200-day — a classic bullish trend signal. Filtered to Biological Products, (No Diagnostic Substances). Updated
Filters2
1–5 of 5
| GILD | Gilead Sciences | 0.08 | 3.68 | +5.41% | +11.18% | +12.70% | Golden | 68.63 | 92.1% | Bullish | Strong Buy | -3.85% | +39.34% | +0.67% | Inverse Head and Shoulders | — | 151.21 | +1.09% |
| CRSP | Crispr Therapeutics Ag | 0.47 | 2.49 | +0.06% | +5.12% | +6.07% | Golden | 52.89 | 43.3% | Bearish | Buy | -28.01% | +27.88% | +1.02% | Double Top | — | 56.47 | -0.79% |
| NVAX | Novavax Inc | 0.55 | 0.53 | +17.43% | +20.98% | +21.10% | Golden | 73.43 | 87.3% | Bullish | Buy | -13.62% | +66.51% | +0.78% | Channel Down | Spinning Top | 10.34 | +0.19% |
| ZURA | Zura Bio Ltd | 0.52 | 0.36 | +1.38% | +6.06% | +12.33% | Golden | 54.52 | 29.6% | Bearish | Buy | -20.61% | +210.85% | +0.26% | Channel Up | — | 5.88 | +3.52% |
| LIMN | Liminatus Pharma, Inc. | 7.49 | 0.42 | +67.27% | +288.51% | +529.73% | Golden | 69.63 | 63.1% | Bullish | Strong Buy | -36.21% | +3948.14% | +1.84% | — | Bearish Marubozu | 3.70 | -2.89% |
Source: SEC EDGAR/XBRL (fundamentals, shares) · Databento EQUS.MINI (EOD prices) · multiples, ratios & technicals computed by tradmap. Financials reflect the latest reported annual period. Informational only — not financial advice.
Cite this data: “Golden Cross Stocks”, tradmap.com, data as of 2026-09-18 — tradmap.com/screener/golden-cross.
Free to cite with attribution and a link.